ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $164K of Arcutis Biotherapeutics, Inc.
Sold$164,220
$22.99Price
7,144Shares
−18%Stake
What ARQT did after the filing
- The stock from Wed, May 6 open, $23.81
- +10.1%
- S&P 500, same days
- +2.6%
Measured over 30 trading days, to the Jun 18 close.
Traded Fri, May 1. Filed Tue, May 5, 8:21 PM ET, after the close. Returns use the May 6 open and the Jun 18 close. Not investment advice.